Aldo N Serafini

Professor

  • 4031 Citations
1972 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Aldo N Serafini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Use of Single-Photon Emission Computed Tomography Imaging for Hypermetabolic Facet Identification in Diagnosis of Cervical and Axial Back Pain

Perez-Roman, R. J., Brusko, G. D., Burks, S. S., Serafini, A. N. & Wang, M. Y., May 2020, In : World neurosurgery. 137, p. e487-e492

Research output: Contribution to journalArticle

  • Efficacy and safety of high-specific-activity 131I-MIBG therapy in patients with advanced pheochromocytoma or paraganglioma

    Pryma, D. A., Chin, B. B., Noto, R. B., Dillon, J. S., Perkins, S., Solnes, L., Kostakoglu, L., Serafini, A. N., Pampaloni, M. H., Jensen, J., Armor, T., Lin, T., White, T., Stambler, N., Apfel, S., DiPippo, V. A., Mahmood, S., Wong, V. & Jimenez, C., May 1 2019, In : Journal of Nuclear Medicine. 60, 5, p. 623-630 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • 20 Scopus citations

    Preoperative SPECT imaging as a tool for surgical planning in patients with axial neck and back pain

    Brusko, G. D., Perez-Roman, R. J., Tapamo, H., Burks, S. S., Serafini, A. N. & Wang, M. Y., Dec 1 2019, In : Neurosurgical focus. 47, 6, 9648.

    Research output: Contribution to journalArticle

    Open Access
  • Phase II study of <sup>90</sup>Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma

    Lossos, I., Fabregas, J. C., Sengul, T., Miao, F., Goodman, D., Serafini, A. N., Hosein, P., Stefanovic, A., Rosenblatt, J. D. & Hoffman, J. E., Jun 1 2015, In : Leukemia and Lymphoma. 56, 6, p. 1750-1755 6 p.

    Research output: Contribution to journalArticle

  • 9 Scopus citations

    Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial

    Ocean, A. J., Pennington, K. L., Guarino, M. J., Sheikh, A., Bekaii-Saab, T., Serafini, A. N., Lee, D., Sung, M. W., Gulec, S. A., Goldsmith, S. J., Manzone, T., Holt, M., O'Neil, B. H., Hall, N., Montero, A. J., Kauh, J., Gold, D. V., Horne, H., Wegener, W. A. & Goldenberg, D. M., Nov 15 2012, In : Cancer. 118, 22, p. 5497-5506 10 p.

    Research output: Contribution to journalArticle

  • 61 Scopus citations